Patients with cerebral hemorrhage should be appropriately treated with hemostatic drugs during the acute stage to achieve the purpose of hemostasis as soon as possible, to prevent further increase of bleeding and obvious occupying effect, which will cause compression of the surrounding brain tissue and cranial nerves and lead to further impairment of brain tissue function. Common clinical hemostatic drugs include snake venom hemagglutinin, aminomethylenic acid, phenol sulfonyl ethylamine, etc. Different hemostatic drugs achieve different purposes of hemostasis and take different paths of hemostasis, and some patients can also receive intramuscular injections of vitamin K to achieve the purpose of hemostasis. Patients with obvious coagulation disorders need to be extra vigilant, and if necessary, platelet count and function should be examined to help determine the cause of cerebral hemorrhage, and symptomatic treatment may be more effective.